Every effort has been made to ensure the accuracy of the information published.
However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the US product label or package insert.

ADEQUAN® I.M.

Luitpold

Brand of Polysulfated Glycosaminoglycan (PSGAG)

Solution 500 mg/5 mL

For Intramuscular Use In Horses

CAUTION: Federal law restricts this drug to use by or on the order of a licensed veterinarian.

DESCRIPTION

Each 5 milliliters of Adequan® i.m. contains 500 mg of Polysulfated Glycosaminoglycan and Water for Injection q.s. Sodium Hydroxide and/or Hydrochloric Acid added when necessary to adjust pH. Sodium Chloride may be added to adjust tonicity.

PHARMACOLOGY

Polysulfated Glycosaminoglycan is chemically similar to the glycosaminoglycans in articular cartilage matrix. PSGAG is a potent proteolytic enzyme inhibitor and diminishes or reverses the pathologic processes of traumatic or degenerative joint disease which result in a net loss of cartilage matrix components. PSGAG improves joint function by reducing synovial fluid protein levels and increasing synovial fluid hyaluronic acid concentration in traumatized equine carpal and hock joints.

TOXICITY

Toxicity studies were conducted in horses. Doses as high as 2,500 mg were administered intramuscularly to 6 horses twice a week for 12 weeks. This dosage is 5 times the recommended dosage and 3 times the recommended therapeutic regimen. Clinical observations revealed no soreness or swelling at the injection site or in the affected joint. No animal had any clinical or laboratory evidence of toxicity.

INDICATIONS

Adequan® i.m. is recommended for the intramuscular treatment of non-infectious degenerative and/or traumatic joint dysfunction and associated lameness of the carpal and hock joints in horses.

CONTRAINDICATIONS

There are no known contraindications to the use of intramuscular Polysulfated Glycosaminoglycan.

WARNING

Do not use in horses intended for human consumption.

DOSAGE AND ADMINISTRATION

The recommended dose of Adequan® i.m. in horses is 500 mg every 4 days for 28 days intramuscularly. The injection site must be thoroughly cleansed prior to injection. Do not mix Adequan® i.m. with other drugs or solvents.

REPRODUCTIVE SAFETY

Studies have not been conducted to establish safety in breeding horses.

Dispose of spent needles in accordance with all federal, state and local environmental laws.